3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Osteosarcoma
1
Neuroblastoma
1
Lung Neoplasms
1
Chickenpox
1
Interventions
Cyclophosphamide
28
Temozolomide
25
Irinotecan
21
dinutuximab
20
Topotecan
15
Magnetic Resonance Spectroscopy
13
Specimen Handling
12
Biopsy
12
naxitamab
11
Granulocyte-Macrophage Colony-Stimulating Factor
11
3-Iodobenzylguanidine
11
Vincristine
10
Etoposide
10
sargramostim
9
Melphalan
9
Isotretinoin
9
fludarabine
8
X-Rays
8
Colony-Stimulating Factors
8
Carboplatin
8
etoposide phosphate
7
Phantoms, Imaging
7
Doxorubicin
7
fludarabine phosphate
6
Stem Cell Transplantation
6
Nuclear Medicine Department, Hospital
6
Eflornithine
6
Thiotepa
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Herpes Zoster Vaccine
×
1 year
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled